nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—MPO—superior mesenteric artery—liver cancer	0.352	0.941	CbGeAlD
Cefdinir—Skin candida—Epirubicin—liver cancer	0.0276	0.0453	CcSEcCtD
Cefdinir—Allergic cutaneous angiitis—Sorafenib—liver cancer	0.0271	0.0445	CcSEcCtD
Cefdinir—Skin candida—Doxorubicin—liver cancer	0.0256	0.042	CcSEcCtD
Cefdinir—Amylase increased—Sorafenib—liver cancer	0.0181	0.0297	CcSEcCtD
Cefdinir—Interstitial pneumonia—Sorafenib—liver cancer	0.0178	0.0293	CcSEcCtD
Cefdinir—Leukocytoclastic vasculitis—Sorafenib—liver cancer	0.0176	0.0288	CcSEcCtD
Cefdinir—Diarrhoea haemorrhagic—Epirubicin—liver cancer	0.0126	0.0207	CcSEcCtD
Cefdinir—Interstitial lung disease—Sorafenib—liver cancer	0.0122	0.02	CcSEcCtD
Cefdinir—Diarrhoea haemorrhagic—Doxorubicin—liver cancer	0.0117	0.0191	CcSEcCtD
Cefdinir—Rhabdomyolysis—Sorafenib—liver cancer	0.00973	0.016	CcSEcCtD
Cefdinir—Ceftriaxone—GLUL—liver cancer	0.00959	0.725	CrCbGaD
Cefdinir—SLC15A1—liver—liver cancer	0.00899	0.024	CbGeAlD
Cefdinir—MPO—liver—liver cancer	0.00809	0.0216	CbGeAlD
Cefdinir—Erythema nodosum—Epirubicin—liver cancer	0.00736	0.0121	CcSEcCtD
Cefdinir—Hepatic function abnormal—Sorafenib—liver cancer	0.00715	0.0117	CcSEcCtD
Cefdinir—Hepatic failure—Sorafenib—liver cancer	0.00696	0.0114	CcSEcCtD
Cefdinir—Erythema nodosum—Doxorubicin—liver cancer	0.00681	0.0112	CcSEcCtD
Cefdinir—Leukorrhea—Epirubicin—liver cancer	0.00679	0.0111	CcSEcCtD
Cefdinir—Renal failure acute—Sorafenib—liver cancer	0.00677	0.0111	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Sorafenib—liver cancer	0.00663	0.0109	CcSEcCtD
Cefdinir—Cardiac failure—Sorafenib—liver cancer	0.00641	0.0105	CcSEcCtD
Cefdinir—Vaginal moniliasis—Epirubicin—liver cancer	0.00631	0.0104	CcSEcCtD
Cefdinir—Leukorrhea—Doxorubicin—liver cancer	0.00628	0.0103	CcSEcCtD
Cefdinir—Vulvovaginal candidiasis—Epirubicin—liver cancer	0.00605	0.00994	CcSEcCtD
Cefdinir—Vaginal moniliasis—Doxorubicin—liver cancer	0.00584	0.00958	CcSEcCtD
Cefdinir—Vulvovaginal mycotic infection—Epirubicin—liver cancer	0.00582	0.00956	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.00563	0.00924	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.00563	0.00924	CcSEcCtD
Cefdinir—Vulvovaginal candidiasis—Doxorubicin—liver cancer	0.0056	0.0092	CcSEcCtD
Cefdinir—Vulvovaginal mycotic infection—Doxorubicin—liver cancer	0.00539	0.00884	CcSEcCtD
Cefdinir—Vaginal discharge—Epirubicin—liver cancer	0.00523	0.00859	CcSEcCtD
Cefdinir—Neutropenia—Sorafenib—liver cancer	0.00505	0.0083	CcSEcCtD
Cefdinir—SLC22A5—liver—liver cancer	0.00489	0.0131	CbGeAlD
Cefdinir—Pneumonia—Sorafenib—liver cancer	0.00485	0.00796	CcSEcCtD
Cefdinir—Vaginal discharge—Doxorubicin—liver cancer	0.00484	0.00795	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00478	0.00784	CcSEcCtD
Cefdinir—Acute coronary syndrome—Sorafenib—liver cancer	0.00475	0.0078	CcSEcCtD
Cefdinir—Renal failure—Sorafenib—liver cancer	0.00474	0.00778	CcSEcCtD
Cefdinir—Myocardial infarction—Sorafenib—liver cancer	0.00472	0.00775	CcSEcCtD
Cefdinir—Jaundice—Sorafenib—liver cancer	0.0047	0.00771	CcSEcCtD
Cefdinir—Stomatitis—Sorafenib—liver cancer	0.0047	0.00771	CcSEcCtD
Cefdinir—Ileus—Epirubicin—liver cancer	0.0045	0.00738	CcSEcCtD
Cefdinir—Haemoglobin—Sorafenib—liver cancer	0.00435	0.00714	CcSEcCtD
Cefdinir—Haemorrhage—Sorafenib—liver cancer	0.00433	0.0071	CcSEcCtD
Cefdinir—Ileus—Doxorubicin—liver cancer	0.00416	0.00683	CcSEcCtD
Cefdinir—Erythema multiforme—Sorafenib—liver cancer	0.00409	0.00671	CcSEcCtD
Cefdinir—Dyskinesia—Epirubicin—liver cancer	0.00339	0.00556	CcSEcCtD
Cefdinir—Leukopenia—Sorafenib—liver cancer	0.00337	0.00553	CcSEcCtD
Cefdinir—Loss of consciousness—Sorafenib—liver cancer	0.00331	0.00543	CcSEcCtD
Cefdinir—Hypertension—Sorafenib—liver cancer	0.00325	0.00534	CcSEcCtD
Cefdinir—Vaginal inflammation—Epirubicin—liver cancer	0.00318	0.00523	CcSEcCtD
Cefdinir—Dry mouth—Sorafenib—liver cancer	0.00313	0.00515	CcSEcCtD
Cefdinir—Dyskinesia—Doxorubicin—liver cancer	0.00313	0.00515	CcSEcCtD
Cefdinir—Melaena—Epirubicin—liver cancer	0.00311	0.0051	CcSEcCtD
Cefdinir—Anaphylactic shock—Sorafenib—liver cancer	0.00307	0.00505	CcSEcCtD
Cefdinir—Candida infection—Epirubicin—liver cancer	0.00304	0.00499	CcSEcCtD
Cefdinir—Shock—Sorafenib—liver cancer	0.00302	0.00496	CcSEcCtD
Cefdinir—Thrombocytopenia—Sorafenib—liver cancer	0.00301	0.00494	CcSEcCtD
Cefdinir—Vaginal infection—Epirubicin—liver cancer	0.00301	0.00493	CcSEcCtD
Cefdinir—Aplastic anaemia—Epirubicin—liver cancer	0.00299	0.00491	CcSEcCtD
Cefdinir—Vaginal inflammation—Doxorubicin—liver cancer	0.00295	0.00484	CcSEcCtD
Cefdinir—Anorexia—Sorafenib—liver cancer	0.00293	0.00481	CcSEcCtD
Cefdinir—Rash maculo-papular—Epirubicin—liver cancer	0.00289	0.00475	CcSEcCtD
Cefdinir—Melaena—Doxorubicin—liver cancer	0.00288	0.00472	CcSEcCtD
Cefdinir—Candida infection—Doxorubicin—liver cancer	0.00281	0.00462	CcSEcCtD
Cefdinir—Vaginal infection—Doxorubicin—liver cancer	0.00278	0.00457	CcSEcCtD
Cefdinir—Aplastic anaemia—Doxorubicin—liver cancer	0.00277	0.00454	CcSEcCtD
Cefdinir—Dyspepsia—Sorafenib—liver cancer	0.0027	0.00444	CcSEcCtD
Cefdinir—Rash maculo-papular—Doxorubicin—liver cancer	0.00268	0.0044	CcSEcCtD
Cefdinir—Decreased appetite—Sorafenib—liver cancer	0.00267	0.00439	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Sorafenib—liver cancer	0.00265	0.00436	CcSEcCtD
Cefdinir—Hepatic function abnormal—Epirubicin—liver cancer	0.00264	0.00434	CcSEcCtD
Cefdinir—Constipation—Sorafenib—liver cancer	0.00263	0.00431	CcSEcCtD
Cefdinir—Hepatic failure—Epirubicin—liver cancer	0.00257	0.00422	CcSEcCtD
Cefdinir—Gastrointestinal pain—Sorafenib—liver cancer	0.00251	0.00413	CcSEcCtD
Cefdinir—Renal failure acute—Epirubicin—liver cancer	0.0025	0.00411	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Epirubicin—liver cancer	0.00245	0.00402	CcSEcCtD
Cefdinir—Hepatic function abnormal—Doxorubicin—liver cancer	0.00245	0.00402	CcSEcCtD
Cefdinir—Abdominal pain—Sorafenib—liver cancer	0.00243	0.00399	CcSEcCtD
Cefdinir—Body temperature increased—Sorafenib—liver cancer	0.00243	0.00399	CcSEcCtD
Cefdinir—Renal impairment—Epirubicin—liver cancer	0.00243	0.00399	CcSEcCtD
Cefdinir—Purpura—Epirubicin—liver cancer	0.0024	0.00394	CcSEcCtD
Cefdinir—Hepatic failure—Doxorubicin—liver cancer	0.00238	0.00391	CcSEcCtD
Cefdinir—Cardiac failure—Epirubicin—liver cancer	0.00237	0.00389	CcSEcCtD
Cefdinir—Renal failure acute—Doxorubicin—liver cancer	0.00232	0.0038	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00227	0.00372	CcSEcCtD
Cefdinir—Hypersensitivity—Sorafenib—liver cancer	0.00226	0.00372	CcSEcCtD
Cefdinir—Renal impairment—Doxorubicin—liver cancer	0.00225	0.00369	CcSEcCtD
Cefdinir—Purpura—Doxorubicin—liver cancer	0.00222	0.00364	CcSEcCtD
Cefdinir—Asthenia—Sorafenib—liver cancer	0.0022	0.00362	CcSEcCtD
Cefdinir—Cardiac failure—Doxorubicin—liver cancer	0.00219	0.0036	CcSEcCtD
Cefdinir—Pruritus—Sorafenib—liver cancer	0.00217	0.00357	CcSEcCtD
Cefdinir—Diarrhoea—Sorafenib—liver cancer	0.0021	0.00345	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00208	0.00342	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00208	0.00342	CcSEcCtD
Cefdinir—Dizziness—Sorafenib—liver cancer	0.00203	0.00334	CcSEcCtD
Cefdinir—Asthma—Epirubicin—liver cancer	0.002	0.00328	CcSEcCtD
Cefdinir—Vomiting—Sorafenib—liver cancer	0.00195	0.00321	CcSEcCtD
Cefdinir—Rash—Sorafenib—liver cancer	0.00194	0.00318	CcSEcCtD
Cefdinir—Dermatitis—Sorafenib—liver cancer	0.00194	0.00318	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00193	0.00316	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00193	0.00316	CcSEcCtD
Cefdinir—Headache—Sorafenib—liver cancer	0.00192	0.00316	CcSEcCtD
Cefdinir—Pancytopenia—Epirubicin—liver cancer	0.0019	0.00311	CcSEcCtD
Cefdinir—Neutropenia—Epirubicin—liver cancer	0.00187	0.00307	CcSEcCtD
Cefdinir—Asthma—Doxorubicin—liver cancer	0.00185	0.00303	CcSEcCtD
Cefdinir—Nausea—Sorafenib—liver cancer	0.00183	0.003	CcSEcCtD
Cefdinir—Pneumonia—Epirubicin—liver cancer	0.00179	0.00294	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00177	0.0029	CcSEcCtD
Cefdinir—Pancytopenia—Doxorubicin—liver cancer	0.00175	0.00288	CcSEcCtD
Cefdinir—Renal failure—Epirubicin—liver cancer	0.00175	0.00287	CcSEcCtD
Cefdinir—Stomatitis—Epirubicin—liver cancer	0.00174	0.00285	CcSEcCtD
Cefdinir—Jaundice—Epirubicin—liver cancer	0.00174	0.00285	CcSEcCtD
Cefdinir—Conjunctivitis—Epirubicin—liver cancer	0.00173	0.00284	CcSEcCtD
Cefdinir—Neutropenia—Doxorubicin—liver cancer	0.00173	0.00284	CcSEcCtD
Cefdinir—Haematuria—Epirubicin—liver cancer	0.0017	0.00279	CcSEcCtD
Cefdinir—Agranulocytosis—Epirubicin—liver cancer	0.00166	0.00273	CcSEcCtD
Cefdinir—Pneumonia—Doxorubicin—liver cancer	0.00166	0.00272	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00163	0.00268	CcSEcCtD
Cefdinir—Renal failure—Doxorubicin—liver cancer	0.00162	0.00266	CcSEcCtD
Cefdinir—Haemoglobin—Epirubicin—liver cancer	0.00161	0.00264	CcSEcCtD
Cefdinir—Jaundice—Doxorubicin—liver cancer	0.00161	0.00264	CcSEcCtD
Cefdinir—Stomatitis—Doxorubicin—liver cancer	0.00161	0.00264	CcSEcCtD
Cefdinir—Conjunctivitis—Doxorubicin—liver cancer	0.0016	0.00263	CcSEcCtD
Cefdinir—Haemorrhage—Epirubicin—liver cancer	0.0016	0.00262	CcSEcCtD
Cefdinir—Haematuria—Doxorubicin—liver cancer	0.00157	0.00258	CcSEcCtD
Cefdinir—Agranulocytosis—Doxorubicin—liver cancer	0.00154	0.00252	CcSEcCtD
Cefdinir—Erythema multiforme—Epirubicin—liver cancer	0.00151	0.00248	CcSEcCtD
Cefdinir—Haemoglobin—Doxorubicin—liver cancer	0.00149	0.00244	CcSEcCtD
Cefdinir—Haemorrhage—Doxorubicin—liver cancer	0.00148	0.00243	CcSEcCtD
Cefdinir—Erythema multiforme—Doxorubicin—liver cancer	0.0014	0.0023	CcSEcCtD
Cefdinir—Flatulence—Epirubicin—liver cancer	0.00137	0.00225	CcSEcCtD
Cefdinir—Agitation—Epirubicin—liver cancer	0.00128	0.0021	CcSEcCtD
Cefdinir—Flatulence—Doxorubicin—liver cancer	0.00127	0.00208	CcSEcCtD
Cefdinir—Leukopenia—Epirubicin—liver cancer	0.00125	0.00205	CcSEcCtD
Cefdinir—Loss of consciousness—Epirubicin—liver cancer	0.00122	0.00201	CcSEcCtD
Cefdinir—Convulsion—Epirubicin—liver cancer	0.00121	0.00198	CcSEcCtD
Cefdinir—Hypertension—Epirubicin—liver cancer	0.0012	0.00197	CcSEcCtD
Cefdinir—Chest pain—Epirubicin—liver cancer	0.00118	0.00195	CcSEcCtD
Cefdinir—Agitation—Doxorubicin—liver cancer	0.00118	0.00194	CcSEcCtD
Cefdinir—Dry mouth—Epirubicin—liver cancer	0.00116	0.0019	CcSEcCtD
Cefdinir—Leukopenia—Doxorubicin—liver cancer	0.00115	0.00189	CcSEcCtD
Cefdinir—Anaphylactic shock—Epirubicin—liver cancer	0.00114	0.00186	CcSEcCtD
Cefdinir—Loss of consciousness—Doxorubicin—liver cancer	0.00113	0.00186	CcSEcCtD
Cefdinir—Shock—Epirubicin—liver cancer	0.00112	0.00183	CcSEcCtD
Cefdinir—Convulsion—Doxorubicin—liver cancer	0.00112	0.00183	CcSEcCtD
Cefdinir—Thrombocytopenia—Epirubicin—liver cancer	0.00111	0.00183	CcSEcCtD
Cefdinir—Hypertension—Doxorubicin—liver cancer	0.00111	0.00183	CcSEcCtD
Cefdinir—Chest pain—Doxorubicin—liver cancer	0.0011	0.0018	CcSEcCtD
Cefdinir—Anorexia—Epirubicin—liver cancer	0.00108	0.00178	CcSEcCtD
Cefdinir—Dry mouth—Doxorubicin—liver cancer	0.00107	0.00176	CcSEcCtD
Cefdinir—Anaphylactic shock—Doxorubicin—liver cancer	0.00105	0.00173	CcSEcCtD
Cefdinir—Shock—Doxorubicin—liver cancer	0.00103	0.0017	CcSEcCtD
Cefdinir—Cefazolin—ALB—liver cancer	0.00103	0.0778	CrCbGaD
Cefdinir—Thrombocytopenia—Doxorubicin—liver cancer	0.00103	0.00169	CcSEcCtD
Cefdinir—Insomnia—Epirubicin—liver cancer	0.00103	0.00169	CcSEcCtD
Cefdinir—Somnolence—Epirubicin—liver cancer	0.00101	0.00166	CcSEcCtD
Cefdinir—Anorexia—Doxorubicin—liver cancer	0.001	0.00164	CcSEcCtD
Cefdinir—Dyspepsia—Epirubicin—liver cancer	0.001	0.00164	CcSEcCtD
Cefdinir—Decreased appetite—Epirubicin—liver cancer	0.000987	0.00162	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Epirubicin—liver cancer	0.00098	0.00161	CcSEcCtD
Cefdinir—Ceftriaxone—ALB—liver cancer	0.000976	0.0738	CrCbGaD
Cefdinir—Constipation—Epirubicin—liver cancer	0.000971	0.00159	CcSEcCtD
Cefdinir—Insomnia—Doxorubicin—liver cancer	0.00095	0.00156	CcSEcCtD
Cefdinir—Somnolence—Doxorubicin—liver cancer	0.000934	0.00153	CcSEcCtD
Cefdinir—Gastrointestinal pain—Epirubicin—liver cancer	0.000929	0.00152	CcSEcCtD
Cefdinir—Dyspepsia—Doxorubicin—liver cancer	0.000925	0.00152	CcSEcCtD
Cefdinir—Decreased appetite—Doxorubicin—liver cancer	0.000913	0.0015	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000907	0.00149	CcSEcCtD
Cefdinir—Constipation—Doxorubicin—liver cancer	0.000899	0.00148	CcSEcCtD
Cefdinir—Abdominal pain—Epirubicin—liver cancer	0.000898	0.00147	CcSEcCtD
Cefdinir—Body temperature increased—Epirubicin—liver cancer	0.000898	0.00147	CcSEcCtD
Cefdinir—Gastrointestinal pain—Doxorubicin—liver cancer	0.000859	0.00141	CcSEcCtD
Cefdinir—Cefalotin—ALB—liver cancer	0.000855	0.0646	CrCbGaD
Cefdinir—Hypersensitivity—Epirubicin—liver cancer	0.000837	0.00137	CcSEcCtD
Cefdinir—Abdominal pain—Doxorubicin—liver cancer	0.000831	0.00136	CcSEcCtD
Cefdinir—Body temperature increased—Doxorubicin—liver cancer	0.000831	0.00136	CcSEcCtD
Cefdinir—Asthenia—Epirubicin—liver cancer	0.000815	0.00134	CcSEcCtD
Cefdinir—Pruritus—Epirubicin—liver cancer	0.000803	0.00132	CcSEcCtD
Cefdinir—Cephalexin—ALB—liver cancer	0.000777	0.0587	CrCbGaD
Cefdinir—Diarrhoea—Epirubicin—liver cancer	0.000777	0.00128	CcSEcCtD
Cefdinir—Hypersensitivity—Doxorubicin—liver cancer	0.000774	0.00127	CcSEcCtD
Cefdinir—Asthenia—Doxorubicin—liver cancer	0.000754	0.00124	CcSEcCtD
Cefdinir—Dizziness—Epirubicin—liver cancer	0.000751	0.00123	CcSEcCtD
Cefdinir—Pruritus—Doxorubicin—liver cancer	0.000743	0.00122	CcSEcCtD
Cefdinir—Vomiting—Epirubicin—liver cancer	0.000722	0.00119	CcSEcCtD
Cefdinir—Diarrhoea—Doxorubicin—liver cancer	0.000719	0.00118	CcSEcCtD
Cefdinir—Rash—Epirubicin—liver cancer	0.000716	0.00118	CcSEcCtD
Cefdinir—Dermatitis—Epirubicin—liver cancer	0.000715	0.00117	CcSEcCtD
Cefdinir—Headache—Epirubicin—liver cancer	0.000711	0.00117	CcSEcCtD
Cefdinir—Dizziness—Doxorubicin—liver cancer	0.000695	0.00114	CcSEcCtD
Cefdinir—Nausea—Epirubicin—liver cancer	0.000675	0.00111	CcSEcCtD
Cefdinir—Vomiting—Doxorubicin—liver cancer	0.000668	0.0011	CcSEcCtD
Cefdinir—Rash—Doxorubicin—liver cancer	0.000663	0.00109	CcSEcCtD
Cefdinir—Dermatitis—Doxorubicin—liver cancer	0.000662	0.00109	CcSEcCtD
Cefdinir—Headache—Doxorubicin—liver cancer	0.000658	0.00108	CcSEcCtD
Cefdinir—Nausea—Doxorubicin—liver cancer	0.000624	0.00102	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—EPT1—liver cancer	0.000251	0.0656	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—STAT4—liver cancer	0.000193	0.0503	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL12B—liver cancer	0.000176	0.046	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—GPX3—liver cancer	0.00014	0.0365	CbGpPWpGaD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.000112	0.0292	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—GPX3—liver cancer	0.000111	0.029	CbGpPWpGaD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.000107	0.0279	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—MTHFR—liver cancer	8.81e-05	0.023	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—GGT1—liver cancer	7.81e-05	0.0204	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—F2—liver cancer	7.74e-05	0.0202	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—MTHFR—liver cancer	7.17e-05	0.0187	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL2—liver cancer	6.73e-05	0.0176	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—GSTM1—liver cancer	6.69e-05	0.0175	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—SERPINE1—liver cancer	6.44e-05	0.0168	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—ALB—liver cancer	6.42e-05	0.0168	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—F2—liver cancer	6.29e-05	0.0164	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—MTHFR—liver cancer	5.7e-05	0.0149	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—STAT3—liver cancer	5.67e-05	0.0148	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC11A2—liver cancer	5.57e-05	0.0145	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC9C1—liver cancer	5.53e-05	0.0144	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—MYO5B—liver cancer	5.53e-05	0.0144	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC40A1—liver cancer	5.31e-05	0.0139	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—SERPINE1—liver cancer	5.24e-05	0.0137	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—ALB—liver cancer	5.23e-05	0.0136	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC11A2—liver cancer	5.17e-05	0.0135	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC9C1—liver cancer	5.13e-05	0.0134	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—MYO5B—liver cancer	5.13e-05	0.0134	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC11A2—liver cancer	5.08e-05	0.0133	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC9C1—liver cancer	5.04e-05	0.0132	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—MYO5B—liver cancer	5.04e-05	0.0132	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—F2—liver cancer	5e-05	0.0131	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC40A1—liver cancer	4.93e-05	0.0129	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—TNF—liver cancer	4.91e-05	0.0128	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC40A1—liver cancer	4.85e-05	0.0127	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—PIK3CA—liver cancer	4.47e-05	0.0117	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IL2—liver cancer	4.24e-05	0.0111	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—SERPINE1—liver cancer	4.16e-05	0.0109	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—ALB—liver cancer	4.15e-05	0.0108	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CDKN2A—liver cancer	4.03e-05	0.0105	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL6—liver cancer	3.96e-05	0.0103	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—TNF—liver cancer	3.79e-05	0.00991	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CDKN1B—liver cancer	3.57e-05	0.00933	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CCND1—liver cancer	3.41e-05	0.0089	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CDKN1A—liver cancer	3.3e-05	0.00861	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—TNF—liver cancer	3.09e-05	0.00806	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—IL6—liver cancer	3.06e-05	0.008	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC11A2—liver cancer	2.83e-05	0.00739	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—MYC—liver cancer	2.73e-05	0.00714	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—TP53—liver cancer	2.72e-05	0.00711	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC40A1—liver cancer	2.7e-05	0.00705	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC11A2—liver cancer	2.63e-05	0.00686	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ATP7B—liver cancer	2.59e-05	0.00676	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ANXA2—liver cancer	2.59e-05	0.00676	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC11A2—liver cancer	2.58e-05	0.00674	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—KRAS—liver cancer	2.53e-05	0.00659	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC40A1—liver cancer	2.51e-05	0.00654	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IL6—liver cancer	2.49e-05	0.00651	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC40A1—liver cancer	2.46e-05	0.00643	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—TNF—liver cancer	2.45e-05	0.0064	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—NR1H4—liver cancer	2.45e-05	0.00639	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ANXA2—liver cancer	2.4e-05	0.00627	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ATP7B—liver cancer	2.4e-05	0.00627	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ATP7B—liver cancer	2.36e-05	0.00617	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ANXA2—liver cancer	2.36e-05	0.00617	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—NR1H4—liver cancer	2.27e-05	0.00593	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—NR1H4—liver cancer	2.23e-05	0.00583	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—HRAS—liver cancer	2.15e-05	0.0056	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—IL6—liver cancer	1.98e-05	0.00517	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—ALB—liver cancer	1.28e-05	0.00335	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—CYCS—liver cancer	1.25e-05	0.00326	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—ALB—liver cancer	1.19e-05	0.0031	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—ALB—liver cancer	1.17e-05	0.00305	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—CYCS—liver cancer	1.16e-05	0.00302	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—CYCS—liver cancer	1.14e-05	0.00297	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—HMOX1—liver cancer	1.08e-05	0.00283	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—HMOX1—liver cancer	1.01e-05	0.00263	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—HMOX1—liver cancer	9.9e-06	0.00258	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—PPARA—liver cancer	8.76e-06	0.00229	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—PPARA—liver cancer	8.13e-06	0.00212	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—PPARA—liver cancer	8e-06	0.00209	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ALB—liver cancer	6.51e-06	0.0017	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ALB—liver cancer	6.04e-06	0.00158	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ALB—liver cancer	5.94e-06	0.00155	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—RAF1—liver cancer	5.89e-06	0.00154	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—RAF1—liver cancer	5.46e-06	0.00143	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—RAF1—liver cancer	5.37e-06	0.0014	CbGpPWpGaD
